VIM (vimentin)

2003-05-01  

Identity

HGNC
LOCATION
10p13
LOCUSID
ALIAS
-
FUSION GENES

Other Information

Locus ID:

NCBI: 7431
MIM: 193060
HGNC: 12692
Ensembl: ENSG00000026025

Variants:

dbSNP: 7431
ClinVar: 7431
TCGA: ENSG00000026025
COSMIC: VIM

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000026025ENST00000224237P08670
ENSG00000026025ENST00000224237V9HWE1
ENSG00000026025ENST00000469543B0YJC5
ENSG00000026025ENST00000478746A0A1B0GTT5
ENSG00000026025ENST00000487938B0YJC4
ENSG00000026025ENST00000497849A0A1B0GVG8
ENSG00000026025ENST00000544301P08670
ENSG00000026025ENST00000544301V9HWE1

Expression (GTEx)

0
500
1000
1500
2000
2500
3000
3500

Pathways

PathwaySourceExternal ID
Epstein-Barr virus infectionKEGGhsa05169
Epstein-Barr virus infectionKEGGko05169
MicroRNAs in cancerKEGGhsa05206
MicroRNAs in cancerKEGGko05206
Immune SystemREACTOMER-HSA-168256
Cytokine Signaling in Immune systemREACTOMER-HSA-1280215
Signaling by InterleukinsREACTOMER-HSA-449147
Muscle contractionREACTOMER-HSA-397014
Striated Muscle ContractionREACTOMER-HSA-390522
Programmed Cell DeathREACTOMER-HSA-5357801
ApoptosisREACTOMER-HSA-109581
Apoptotic execution phaseREACTOMER-HSA-75153
Apoptotic cleavage of cellular proteinsREACTOMER-HSA-111465
Caspase-mediated cleavage of cytoskeletal proteinsREACTOMER-HSA-264870
Interleukin-4 and 13 signalingREACTOMER-HSA-6785807

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
376493222024Correlation between E-cadherin/β-catenin, Vimentin expression, clinicopathologic features and drug resistance prediction in naïve prostate cancer: A molecular and clinical study.0
377489342024Vimentin at the core of wound healing.1
380070052024Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients.1
380123572024Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance.4
380785072024Phosphorylated vimentin at Ser72 is associated with epithelial-mesenchymal transition in lupus nephritis.0
382431182024Circular RNA cVIM promotes hepatic stellate cell activation in liver fibrosis via miR-122-5p/miR-9-5p-mediated TGF-β signaling cascade.2
383834792024A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity.1
384595132024CircGLIS3 promotes gastric cancer progression by regulating the miR-1343-3p/PGK1 pathway and inhibiting vimentin phosphorylation.0
386851252024Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer.1
386918682024EP300 through upregulating the expression of vimentin to promote the progression of chordoma.0
376493222024Correlation between E-cadherin/β-catenin, Vimentin expression, clinicopathologic features and drug resistance prediction in naïve prostate cancer: A molecular and clinical study.0
377489342024Vimentin at the core of wound healing.1
380070052024Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients.1
380123572024Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance.4
380785072024Phosphorylated vimentin at Ser72 is associated with epithelial-mesenchymal transition in lupus nephritis.0

Citation

Dessen P

VIM (vimentin)

Atlas Genet Cytogenet Oncol Haematol. 2003-05-01

Online version: http://atlasgeneticsoncology.org/gene/42791/vim-(vimentin)